Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
PROK | PROKIDNEY CORP. | Director, 10%+ Owner | $171M | +$54.7M | +47.2% | Jun 13, 2024 |
RPRX | Royalty Pharma plc | CEO, Chairman of the Board, Director, 10%+ Owner | $9.81M | Jun 28, 2023 | ||
EPZM | Epizyme, Inc. | Director, 10%+ Owner | Aug 12, 2022 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|